Two Sigma Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Two Sigma Securities’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$850K	Sell	5,120 -5,516	-52%	-$905K	0.1%	261
2025 Q4	$1.7M	Sell	10,636 -699	-6%	-$96K	0.23%	86
2025 Q3	$1.06M	Buy	+11,335	New	+$801K	0.16%	147
2025 Q1	–	Sell	-3,593	Closed	-$323K	–	1871
2024 Q4	$323K	Buy	+3,593	New	+$423K	0.04%	597
2024 Q3	–	Sell	-3,657	Closed	-$415K	–	3288
2024 Q2	$415K	Buy	3,657 +1,342	+58%	+$144K	0.01%	1707
2024 Q1	$307K	Buy	+2,315	New	+$302K	﹤0.01%	1940
2022 Q4	–	Sell	-1,509	Closed	-$212K	–	2954
2022 Q3	$212K	Buy	1,509 +101	+7%	+$18.5K	0.01%	1908
2022 Q2	$190K	Buy	+1,408	New	+$240K	0.01%	1669
2019 Q1	–	Sell	-328	Closed	-$216K	–	2177
2018 Q4	$216K	Buy	+328	New	+$344K	﹤0.01%	1650
2018 Q1	–	Sell	-732	Closed	-$1.14M	–	2830
2017 Q4	$1.14M	Buy	+732	New	+$1.12M	0.03%	388
2017 Q3	–	Sell	-206	Closed	-$260K	–	1082
2017 Q2	$260K	Buy	+206	New	+$208K	0.05%	413
2016 Q3	–	Sell	-677	Closed	-$382K	–	730
2016 Q2	$382K	Buy	+677	New	+$424K	0.21%	141

Other funds holding LABU

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Two Sigma Securities's LABU Position: Q1 2026 in Review

Two Sigma Securities reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 52% in Q1 2026, selling an estimated $905K and leaving 5,120 shares worth $850K. The position accounts for 0.1% of the portfolio, ranked #261.

Two Sigma Securities first reported a position in LABU in Q2 2016 and has held it in 12 quarters since. The position peaked at $1.7M in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

Two Sigma Securities held 5,120 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $850K as of Q1 2026.
Two Sigma Securities sold 5,516 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $905K.
Direxion Daily S&P Biotech Bull 3X ETF made up 0.1% of Two Sigma Securities's portfolio in Q1 2026, its #261 holding.
Two Sigma Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2016 and has held it in 12 quarters since.
Two Sigma Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1.7M in Q4 2025.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.